Диссертация (1140235), страница 30
Текст из файла (страница 30)
McGraw HillProfessional Publishing. – 2010. – РР.604-646.168.Delisle H. Programming of chronic disease by impaired fetal nutrition/ evidenceand complications for policy and intervention strategies. WHO.- 2001.-РР.93.169.Djordjević P. B., Dimitrijević-Srećković V., Bumbaširević V., Čolović R. Apoptosis of human fetal pancreatic islets during short-term culture // Arch.
Biol. Sci. - 2009.-№. 61 (1). – P. 9-15.170.Dorsche Н.Н., Fait K., Madsen O. et al. Detection of proinsulin, C-peptide, insulin-A-chain, and Glicentin in pancreatic islet cells of early human fetogenesis. //Acta histochem. - 1991. – 91. - № 1. - P. 39-42.171.Dosoudilova M., Lichnovsky V., Lojda Z.
Enzyme histochemistry in the developing pancreas of human fetuses. // Funct. and Dev. Morphol. - 1992. – 2. - № 1. - P. 44.172.Duvillie B., Attali M., Bounacer A. The mesenchyme controls the timing of pancreatic β-cell differentiation. // Diabetes. – 2006. – №. 55(3). – РР.582-589.173.Edlund H. Developmental biology of the pancreas.// Diabetes. – 2001. 50(supple1). – PP.5-9.174.Farrar D, Duley L, Medley N, Lawlor DA.
Different strategies for diagnosing gestational diabetes to improve maternal and infant health. Cochrane Database Syst Rev. –2015. - 1:CD007122.175.Fowden AL. Fetal metabolism and energy balance. In: Thorburn GD, Harding R(eds). Textbook of Fetal Physiology. Oxford: Oxford University Press, 1994, pp.70–82.176.Fowden A., Giussani D., Forhead A.
Intrauterine programming of physiologicalsystems: causes and consequences. Physiology. – 2006. - №.21. – РР.29-37.177.Gascoin G., Flamant C. Long-term outcome in context of intrauterine growth restriction and/or small for gestational age of newborns. J Obstet Gynecol Biol Reprod(Paris). – 2013. - №.42(8). – РР.911-920.178.Gittes G.K., Galante P.E., Hanahan D. et al.
Lineage-specific morphogenesis inthe developing pancreas: role of mesenchymal factors. //J. Development. - 1996. – 122. № 2. - P. 73-77.179.Girard, J. Hormonal control of the development of hepatic hluconeogenesis in theneonate.
// Ann. Endocrinol. Paris. - 1988. -V.49:287-293.180.Gluckman P.D., Hanson M.A., Low F.M. The role of developmental plasticity andepigenetics in human health. Birth Defects Res. C Embrio Today. – 2011.- №93. –РР.12-18181.Gluckman P, Harding J. The regulation of fetal growth. In: Hernandez M, ArgenteJ (eds). Human growth: Basic and clinical aspects. Amsterdam: International CongressSeries 973, Excerpta Medica. – 1992.- РР.
253–60.171182.Harding G.E. The nutritional basis of the fetal origins of adult disease. International Journal of Epidemiology. – 2001. -№.30. – РР.15-23.183.Hata K., Hata T., Kitao M. Ultrasonographic identification and measurement ofthe fetal pancreas in utero. Int. J. Obstet. Gynecol. – 1988.-№26.-РР.61-64.184.Нata T., Deter R.L. A review of fetal organ measurements obtained with ultrasound: normal growth. J. Clin. Ultrasound.-1992.- Vol.
20.- №3.- P. 155.185.Haymond, M.D. Hypoglycemia in infants and children. // Endocrinol. Metab.Clin. North. Am.-1989. - V.18.- №.l.-РР. 211-259.186.Hill L.M., Peterson C., Rivelo D. et al. Sonographic detection of the fetal pancreas. J. Clin. Ultrasound.- 1989.-№.17.- РР.475-479.187.Hirshberg A, Levine LD, Schwartz N, Durnwald CP. Reversed enddiastolic flow in the middle cerebral artery preceding death in a normally grown fetus.//Obstet Gynecol.-2013-Vol. 122.-№ 2-Р.507-509.188.Hoe, F.M. et al. Clinical Features and insulin regulation in infants with syndrome:prolonged neonatal hyperinsulinism. // J. Pediatr. — 2006.
-V.148.-РР. 207-212.189.Hofman P.L. et.al. Insulin resistance in short children with intrauterine growth retardation. J. Clin Endocr Metabol.- 1997.-№.82.-РР.402-406.190.Holliday R. Epigenetic inheritance based on DNA methylation. EXS.- 1993.№.53.РР.452-468.191.Holness M., Langdown M.L., Sugden M.C. Early-life programming of susceptibility to dysregulation of glucose metabolism and the development of type 2 diabetesmellitus.
Biochem J.- 2000.-№349.-РР.657-665.192.Honglu D.P. Shuo Xiao M.S., Fei Zhao B.S. Uterine luminal epithelium-specificproline-rich acidic protein 1 (PRAP1) as a marker for successful embryo implantation //Fertil. Steril. -2010.–Vol. 94.–P. 2808-2811.193.Hormi K., Lehy T. Developmental expression of transforming growth factor andepidermal growth factor receptor proteins in the human pancreas and digestive tract. //J.Cell and Tissue Research.
- 1994. – 278. - № 3.- P. 439-450.194.Jacqueline E.A., Bamfo K., Anthony O. Odibo. Diagnosis and Management of Fetal Growth Restriction : Review Article // Journal of Pregnancy -2011- Article ID640715- 15 pages195.Jennings R. E., Berry A.A., Strutt J.P., Gerrard D.T., Hanley N.A. Human pancreas development // Development,. – 2015. – 142. – P.3126-3137.196.Jiang F-X., Cram D.S., De Aizpurua H.J., Harrison L.C.
Laminin-1 promotes differentiation of fetal mouse pancreatic p-cell. //Diabetes. - 1999. – 48. - №4. - P. 722-730.197.Johansson M., Andersson A., Carlsson P-O., Jansson L. Perinatal development ofthe pancreatic islet microvasculature in rats.// J.Anat. – 2006. –№.208(2). – PP.191-196.198.Kim S.K., Hebrok M., Melton D.A. Notochord to endoderm signaling is requiredfor pancreas development. //J.
Development. - 1997. – 124. - №21. - P. 39-44.199.Krivova Y.S., Proshchina A.E., Barabanov V.M., Saveliev S.V. Development ofthe Islets of Langerhans in the Human Fetal Pancreas. In: Pancreas: Anatomy, diseasesand health implications. Chapter 2. Editors: Akiko Satou, Nana Nakamura. – Nova Science Publishers Inc.
– 2012. – pp.53-87.200.Larsson L.I. On the development of the islets of Langergans. Microsc Res Tech.1998.-№.15.- 43.- Vol.4.-РР.284–291.172201.Lee V.R., Pilliod R.A., Frias A.E., Rasanen J.P., Shaffer B.L., Caughey A.B.When is the optimal time to deliver late preterm IUGR fetuses with abnormal umbilicalartery Dopplers?//J Matern Fetal Neonatal Med. - 2015.- №.10-Р.1-6.202.Lichter-Konecki U., Moter S.E., Krawisz B.R. et al. Expression patterns of murine lysosome-associated membrane protein 2 (Lamp-2) transcripts during morphogenesis. //J.
Differentiation. - 1999. – 65. - № 1. - P. 43 - 58.203.Madsen O.D. Pancreatic development and maturation of the islet β-cell studies ofpluripotent islet cultures /Ole D. Madsen, J.Jensen, N.Blum et al. //Eur. J. Biochem. –1996.–242. – №3.– P.435-445.204.Malatesta М.J., Zancanaro C., Marcheggiani F. et al. Ultrastructural, morphometrical and immunocytochemical analyses of the exocrine pancreas in a hibernating dormouse // Cell and Tissue Research.
- 1998. – 292. - №3. - P.531-541.205.Manning F.A. The Alpha-Omega Theory: the prenatal origins of postnatal disease.OBJ Management.- 2000.-№.20.- РР.30-45.206.Martinez A., Cuttitta F., Teitelman G. Expression pattern for adrenomedullin during pancreatic development in the reveals a common precursor with other endocrine celltypes. // J. Cell and Tissue Research. - 1998.
– 293. - № 1. - P. 95-100.207.McCowan L.M., Roberts C.T., Dekker G.A. SCOPE consortium. Risk factors forsmall-for-gestational-age infants by customized birthweight centiles: data from an international prospective cohort study.
BJOG 2010.-№117(13).РР.1599-1607.208.McIntire D.D., Bloom S.L., Casey B.M., Leveno K.J. Birth weight in relation tomorbidity and mortality among newborn infants. N Engl J Med.- 1999.- №340.-РР.12341238.209.Merz E. Ultrasound in Obstetrics and Gynecology. Vol.1: Obstetrics. Stuttgard,New York:Thieme.- 2005.-Р.636.210.Miralles F., Czernichow P., Scharfmann R. Follistatin regulates the relative proportions of endocrine versus exocrine tissue during pancreatic development. J.
Development.- 1998.-№.125(6).РР.52–59.211.Nieto-Díaz A, Villar J, Matorras-Weinig R, Valenzuela-Ruìz P. Intrauterinegrowth retardation at term: association between anthropometric and endocrine parameters. //Acta Obstet Gynecol Scand. -1996. – Vol.75.-№2.-Р.127-131.212.Offield M.F., Jetton T.L., Labosky P.A. et al. PDX-1 is required for pancreaticoutgrowth and differentiation of the rostral duodenum. // J. Development. - 1996. – 122. № 3.- P. 69-74.213.Persson-Sjögren S., Forsgren S., Täljedal I.-B. Mouse islets cultured with vasoactive intestinal polypeptide: Effects on insulin release and immunoreactivity for tyrosinehydroxylase // Pancreas.
– 2001. – 22.- P.84-90.214.Persson-Sjögren S., Forsgren S., Täljedal I.-B. Tyrosine hydroxylase in mousepancreatic islet cells, in situ and after syngeneic transplantation to kidney // Histol Histopathol. – 2002. – 17. – P.113-121.215.Peters J., Jorgensen A., Kluppel G. Ontogeny differentiation and growth of theendocrine pancreas. // J. Virchows Archiv. - 2000.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
